Standard BioTools Inc. (NASDAQ: LAB) announced it has agreed to sell its Mass Cytometry business to Multiplex Bio, a newly ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions